Maverick Capital’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-39,596
| Closed | -$1.27M | – | 257 |
|
|
2024
Q2 | $1.27M | Buy |
39,596
+30,723
| +346% | +$989K | 0.02% | 181 |
|
|
2024
Q1 | $344K | Buy |
+8,873
| New | +$344K | 0.01% | 311 |
|
|
2023
Q3 | – | Sell |
-10,401
| Closed | -$224K | – | 347 |
|
|
2023
Q2 | $224K | Sell |
10,401
-895
| -8% | -$19.2K | ﹤0.01% | 382 |
|
|
2023
Q1 | $271K | Buy |
11,296
+555
| +5% | +$13.3K | 0.01% | 426 |
|
|
2022
Q4 | $249K | Sell |
10,741
-3,991
| -27% | -$92.6K | 0.01% | 336 |
|
|
2022
Q3 | $236K | Buy |
+14,732
| New | +$236K | 0.01% | 286 |
|
|
2021
Q3 | – | Sell |
-33,751
| Closed | -$798K | – | 662 |
|
|
2021
Q2 | $798K | Buy |
+33,751
| New | +$798K | 0.01% | 339 |
|
|
2021
Q1 | – | Sell |
-6,926
| Closed | -$139K | – | 734 |
|
|
2020
Q4 | $139K | Buy |
+6,926
| New | +$139K | ﹤0.01% | 559 |
|
|
2019
Q2 | – | Sell |
-395,080
| Closed | -$5.98M | – | 290 |
|
|
2019
Q1 | $5.98M | Buy |
+395,080
| New | +$5.98M | 0.08% | 154 |
|
|
2018
Q4 | – | Sell |
-421,993
| Closed | -$6.22M | – | 269 |
|
|
2018
Q3 | $6.22M | Sell |
421,993
-2,597
| -0.6% | -$38.3K | 0.08% | 146 |
|
|
2018
Q2 | $10.1M | Buy |
+424,590
| New | +$10.1M | 0.12% | 80 |
|